Acute Care Volume 23, Issue 3

Medication Safety Alert! February 8, 2018

In this week's issue:

Featured article

Hyperkalemia is a serious, potentially lethal electrolyte disturbance that requires medical treatment without delay if it is severe enough to cause disturbances in cardiac conduction. Although hyperkalemia treatment guidelines in the literature vary,1 many organizations begin treatment with the administration of one or more intravenous (IV) bolus doses of 50% dextrose and an IV bolus dose of 10 units of insulin. Some organizations use a rapid-acting insulin (i.e., insulin aspart, insulin lispro) rather than short-acting insulin (i.e., regular insulin) because it may decrease the incidence of...

Access this Newsletter

Purchasing Options

Purchase access to this individual issue

Purchase a year's access to this bi-weekly publication (25 issues)